|
1
|
Klug LR, Khosroyani HM, Kent JD and
Heinrich MC: New treatment strategies for advanced-stage
gastrointestinal stromal tumours. Nat Rev Clin Oncol. 19:328–341.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mitani S, Kito Y, Hino K, Kawakami K,
Izawa N, Hanamura F, Yamamoto Y, Shoji H, Komori A, Boku S, et al:
Real-World treatment sequencing in vulnerable patients with
metastatic colorectal cancer: A multicenter retrospective study.
Target Oncol. 18:707–715. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hamamoto Y, Piao Y and Makiyama A:
Achieving sequential therapy in advanced gastric cancer: The
importance of appropriate patient management for the elderly and/or
those with ascites. Gastric Cancer. 23:363–372. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ülger Y and Delik A: Paraneoplastic
syndrome frequency and prognostic effect in hepatocellular
carcinoma patients. Eur J Gastroenterol Hepatol. 34:769–773. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Efthymiou C, Spyratos D and Kontakiotis T:
Endocrine paraneoplastic syndromes in lung cancer. Hormones
(Athens). 17:351–358. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haap M, Gallwitz B, Thamer C, Müssig K,
Häring HU, Kanz L and Hartmann JT: Symptomatic hypoglycemia during
imatinib mesylate in a non-diabetic female patient with
gastrointestinal stromal tumor. J Endocrinol Invest. 30:688–692.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Demirci A, Bal O, Durnali A, Ekinci AŞ,
Eşbah O, Alkiş N and Oksüzoğlu B: Sunitinib-induced severe
hypoglycemia in a diabetic patient. J Oncol Pharm Pract.
20:469–472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Honka H and Salehi M: Postprandial
hypoglycemia after gastric bypass surgery: From pathogenesis to
diagnosis and treatment. Curr Opin Clin Nutr Metab Care.
22:295–302. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bodnar TW, Acevedo MJ and Pietropaolo M:
Management of non-islet-cell tumor hypoglycemia: A clinical review.
J Clin Endocrinol Metab. 99:713–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hirai H, Ogata E, Ohki S, Fukuda I, Tanaka
M, Watanabe T and Satoh H: Hypoglycemia associated with a
gastrointestinal stromal tumor producing high-molecular-weight
insulin growth factor II: A case report and literature review.
Intern Med. 55:1309–1314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Daughaday WH, Emanuele MA, Brooks MH,
Barbato AL, Kapadia M and Rotwein P: Synthesis and secretion of
insulin-like growth factor II by a leiomyosarcoma with associated
hypoglycemia. N Engl J Med. 319:1434–1440. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rikhof B, van der Graaf WT, Suurmeijer AJ,
van Doorn J, Meersma GJ, Groenen PJ, Schuuring EM, Meijer C and de
Jong S: ‘Big’-insulin-like growth factor-II signaling is an
autocrine survival pathway in gastrointestinal stromal tumors. Am J
Pathol. 181:303–312. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tani Y, Tateno T, Izumiyama H, Doi M,
Yoshimoto T and Hirata Y: Defective expression of prohormone
convertase 4 and enhanced expression of insulin-like growth factor
II by pleural solitary fibrous tumor causing hypoglycemia. Endocr
J. 55:905–911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertherat J, Logié A, Gicquel C,
Mourriéras F, Luton JP and Le Bouc Y: Alterations of the 11p15
imprinted region and the IGFs system in a case of recurrent
non-islet-cell tumour hypoglycaemia (NICTH). Clin Endocrinol (Oxf).
53:213–220. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hodzic D, Delacroix L, Willemsen P,
Bensbaho K, Collette J, Broux R, Lefèbvre P, Legros JJ, Grooteclaes
M and Winkler R: Characterization of the IGF system and analysis of
the possible molecular mechanisms leading to IGF-II overexpression
in a mesothelioma. Horm Metab Res. 29:549–555. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dynkevich Y, Rother KI, Whitford I,
Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N,
Shanik MH, et al: Tumors, IGF-2, and hypoglycemia: Insights from
the clinic, the laboratory, and the historical archive. Endocr Rev.
34:798–826. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van Doorn J: Insulin-like growth factor-II
and bioactive proteins containing a part of the E-domain of
pro-insulin-like growth factor-II. Biofactors. 46:563–578. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hayashi H, Tanishima S, Fujii K, Mori R,
Okada C, Yanagita E, Shibata Y, Matsuoka R, Amano T, Yamada T, et
al: Clinical impact of a cancer genomic profiling test using an
in-house comprehensive targeted sequencing system. Cancer Sci.
111:3926–3937. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cingolani P, Platts A, Wang LL, Coon M,
Nguyen T, Wang L, Land SJ, Lu X and Ruden DM: A program for
annotating and predicting the effects of single nucleotide
polymorphisms, SnpEff: SNPs in the genome of Drosophila
melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 6:80–92.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Konno R, Matsui T, Ito H, Kawashima Y,
Itakura M and Kodera Y: Highly accurate and precise quantification
strategy using stable isotope dimethyl labeling coupled with
GeLC-MS/MS. Biochem Biophys Res Commun. 550:37–42. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
ElSayed NA, Aleppo G, Aroda VR, Bannuru
RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D,
Johnson EL, et al: 6. Glycemic targets: Standards of care in
diabetes-2023. Diabetes Care. 46:S97–S110. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aktas A, Lorton CM, Griffin O, Higgins K,
Roulston F, Stewart G, Corkery N, Barnes E and Walsh D: Application
of the 2011 international consensus cancer cachexia classification
in routine oncology dietetic practice: An observational study. Nutr
Clin Pract. 38:790–797. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kawai S, Ariyasu H, Uraki S, Takeshima K,
Morita S, Inaba H, Iwakura H, Doi A, Ohashi T, Kawago M, et al:
Imbalanced expression of IGF2 and PCSK4 is associated with
overproduction of big IGF2 in SFT With NICTH: A pilot study. J Clin
Endocrinol Metab. 103:2728–2734. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors: Pathology and prognosis at different sites. Semin
Diagn Pathol. 23:70–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kanai Y, Nishihara H, Miyagi Y, Tsuruyama
T, Taguchi K, Katoh H, Takeuchi T, Gotoh M, Kuramoto J, Arai E, et
al: The Japanese Society of pathology guidelines on the handling of
pathological tissue samples for genomic research: Standard
operating procedures based on empirical analyses. Pathol Int.
68:63–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamasaki H, Itawaki A, Morita M, Miyake H,
Yamamoto M, Sonoyama H, Tanaka S, Notsu M, Yamauchi M, Fujii Y, et
al: A case of insulin-like growth factor 2-producing
gastrointestinal stromal tumor with severe hypoglycemia. BMC Endocr
Disord. 20:602020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Raut CP, Posner M, Desai J, Morgan JA,
George S, Zahrieh D, Fletcher CD, Demetri GD and Bertagnolli MM:
Surgical management of advanced gastrointestinal stromal tumors
after treatment with targeted systemic therapy using kinase
inhibitors. J Clin Oncol. 24:2325–2331. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Blay JY, Kang YK, Nishida T and von Mehren
M: Gastrointestinal stromal tumours. Nat Rev Dis Primers. 7:222021.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Steigen SE, Schaeffer DF, West RB and
Nielsen TO: Expression of insulin-like growth factor 2 in
mesenchymal neoplasms. Mod Pathol. 22:914–921. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
DeMatteo RP, Lewis JJ, Leung D, Mudan SS,
Woodruff JM and Brennan MF: Two hundred gastrointestinal stromal
tumors: Recurrence patterns and prognostic factors for survival.
Ann Surg. 231:51–58. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Joensuu H: Gastrointestinal stromal tumor
(GIST). Ann Oncol. 17 (Suppl 10):x280–x286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ata F, Choudry H, Khan AA, Anum Khamees I,
Al-Sadi A, Mohamed A, Malkawi L and Aljaloudi E: A systematic
review of literature on insulin-like growth factor-2-mediated
hypoglycaemia in non-islet cell tumours. Endocrinol Diabetes Metab.
7:e004712024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kondo S, Hashimoto H, Nakajima K, Miura S,
Sakuma J, Fukuda I, Noie T and Morikawa T: Insulin-like growth
factor II-producing colonic carcinoma presenting with non-islet
cell tumor hypoglycemia: An autopsy report revealing neuroendocrine
differentiation in the metastatic foci and literature review.
Pathol Int. 72:193–199. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pink D, Schoeler D, Lindner T,
Thuss-Patience PC, Kretzschmar A, Knipp H, Vanhoefer U and
Reichardt P: Severe hypoglycemia caused by paraneoplastic
production of IGF-II in patients with advanced gastrointestinal
stromal tumors: A report of two cases. J Clin Oncol. 23:6809–6811.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Escobar GA, Robinson WA, Nydam TL, Heiple
DC, Weiss GJ, Buckley L, Gonzalez R and McCarter MD: Severe
paraneoplastic hypoglycemia in a patient with a gastrointestinal
stromal tumor with an exon 9 mutation: A case report. BMC Cancer.
7:132007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tan G, Teo M and Choo SP: Hypoglycaemia in
a 63-year-old female with a large, recurrent, metastatic
gastrointestinal stromal tumour (GIST). J Gastrointest Cancer.
42:263–265. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dimitriadis GK, Gopalakrishnan K, Rao R,
Grammatopoulos DK, Randeva HS, Weickert MO and Murthy N: Severe
paraneoplastic hypoglycemia secondary to a gastrointestinal stromal
tumour masquerading as a stroke. Endocrinol Diabetes Metab Case
Rep. 2015:1500622015.PubMed/NCBI
|
|
40
|
Wilson JM, Ginsberg J, Cutts K and Urban
S: A case of non-islet cell tumor hypoglycemia (NICTH) associated
with gastrointestinal stromal tumor (GIST). Am J Case Rep.
18:984–988. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Haeri NS, Mahmud H and Korytkowski MT:
Paraneoplastic hypoglycemia leading to insulin independence in a
patient with type 1 diabetes. AACE Clin Case Rep. 7:376–378. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Takebayashi K, Furukawa S, Okumura T, Kubo
M, Ujiie A, Yamauchi M, Shinozaki H, Hara K, Tsuchiya T, Ono Y, et
al: Severe non-islet cell hypoglycemia from ileum-origin
gastrointestinal stromal tumor producing insulin-like growth
factor-2 in a patient with liver cirrhosis due to chronic hepatitis
B. J Clin Med Res. 12:824–830. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Davda R and Seddon BM: Mechanisms and
management of non-islet cell tumour hypoglycaemia in
gastrointestinal stromal tumour: Case report and a review of
published studies. Clin Oncol (R Coll Radiol). 19:265–268. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hamberg P, de Jong FA, Boonstra JG, van
Doorn J, Verweij J and Sleijfer S: Non-islet-cell tumor induced
hypoglycemia in patients with advanced gastrointestinal stromal
tumor possibly worsened by imatinib. J Clin Oncol. 24:e30–e31.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Beckers MM, Slee PH and van Doorn J:
Hypoglycaemia in a patient with a gastrointestinal stromal tumour.
Clin Endocrinol (Oxf). 59:402–404. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dean K, Hsieh J, Morosky C and Hoffman J:
Gastrointestinal stromal tumor of the pelvic soft tissue presenting
with symptomatic hypoglycemia: A case report and brief review of
current literature of non-islet cell tumor-induced hypoglycemia.
Gynecol Oncol Case Rep. 2:87–88. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Singhal A, Hadi R, Mehrotra K, Rastogi S
and Masood S: Paraneoplastic Hypoglycaemia: A rare manifestation of
pelvic gastrointestinal stromal tumour. J Clin Diagn Res.
11:Xd01–Xd02. 2017.PubMed/NCBI
|
|
48
|
Saeed Z, Taleb S and Evans-Molina C: A
case of extragastrointestinal stromal tumor complicated by severe
hypoglycemia: A unique presentation of a rare tumor. BMC Cancer.
16:9302016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rikhof B, Van Den Berg G and Van Der Graaf
WT: Non-islet cell tumour hypoglycaemia in a patient with a
gastrointestinal stromal tumour. Acta Oncol. 44:764–766. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Guiteau J, Fanucchi M, Folpe A, Staley CA
III and Kooby DA: Hypoglycemia in the setting of advanced
gastrointestinal stromal tumor. Am Surg. 72:1225–1230. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dhali A, Ray S, Dhali GK, Ghosh R and
Sarkar A: Refractory hypoglycaemia in a localised gastrointestinal
stromal tumour: Case report. Int J Surg Case Rep. 83:1060232021.
View Article : Google Scholar : PubMed/NCBI
|
